Hypercalcemia-Induced Hypokalemic Metabolic Alkalosis in a Multiple Myeloma Patient: The Risk of Furosemide Use
暂无分享,去创建一个
[1] S. Levine,et al. Hypercalcemia in the Intensive Care Unit , 2015, Journal of intensive care medicine.
[2] B. Wall,et al. Multiple myeloma with hypercalcemia and chloride resistant metabolic alkalosis. , 2011, Tennessee medicine : journal of the Tennessee Medical Association.
[3] E. Brown,et al. Physiology and pathophysiology of the calcium-sensing receptor in the kidney. , 2010, American journal of physiology. Renal physiology.
[4] H. Boorugu,et al. Amikacin-induced type 5 Bartter-like syndrome with severe hypocalcemia. , 2009, Journal of postgraduate medicine.
[5] S. Sasaki,et al. Calcium-alkali syndrome due to vitamin D administration and magnesium oxide administration. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[6] G. Clines,et al. Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone. , 2005, Endocrine-related cancer.
[7] T. Chau,et al. Acquired bartter-like syndrome associated with gentamicin administration. , 2005, The American journal of the medical sciences.
[8] A. F. Stewart. Hypercalcemia Associated with Cancer , 2005 .
[9] M. Hediger,et al. The calcium-sensing receptor is required for normal calcium homeostasis independent of parathyroid hormone. , 2003, The Journal of clinical investigation.
[10] S. Hebert. Extracellular calcium-sensing receptor: implications for calcium and magnesium handling in the kidney. , 1996, Kidney international.
[11] A. F. Stewart. Clinical practice. Hypercalcemia associated with cancer. , 2005, The New England journal of medicine.
[12] J. Seymour,et al. Calcitriol: the major humoral mediator of hypercalcemia in Hodgkin's disease and non-Hodgkin's lymphomas. , 1993, Blood.